1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Amentia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlemeyer, B; Krieglstein, J | 1 |
| Benmehdi, H; Bensaid, O; Clayette, P; Dereuddre-Bosquet, N; Dive, G; Heymans, F; Lamouri, A; Martin, M; Redeuilh, C; Sallem, W; Serradji, N | 1 |
| Clayette, P; Dereuddre-Bosquet, N; Dive, G; Heymans, F; Sallem, W; Serradji, N | 1 |
| Darlington, CL; Maclennan, K; Smith, PF | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Amentia
| Article | Year |
|---|---|
Neuroprotective effects of Ginkgo biloba extract.
Topics: Animals; Antioxidants; Cerebrovascular Circulation; Clinical Trials as Topic; Dementia; Ginkgo biloba; Humans; Molecular Structure; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Nitric Oxide; Phytotherapy; Plant Extracts; Plant Leaves; Platelet Activating Factor | 2003 |
The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF).
Topics: Animals; Cerebrovascular Circulation; Dementia; Diterpenes; Free Radical Scavengers; Ginkgo biloba; Ginkgolides; Humans; Lactones; Memory; Neuroprotective Agents; Plant Extracts; Plant Leaves; Platelet Activating Factor; Trees | 1996 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Amentia
| Article | Year |
|---|---|
Structure-activity relationships in platelet-activating factor. Part 13: synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 or pure antiretroviral activity.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Retroviral Agents; Dementia; Dose-Response Relationship, Drug; HIV-1; Humans; Piperazines; Platelet Activating Factor; Structure-Activity Relationship | 2006 |
Structure-activity relationships in platelet-activating factor. Part 14: synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 activity.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Dementia; Dose-Response Relationship, Drug; HIV-1; Humans; Piperazines; Platelet Activating Factor; Structure-Activity Relationship | 2006 |
Ginkgo biloba for dementia.
Topics: Antioxidants; Clinical Trials as Topic; Dementia; Dementia, Multi-Infarct; Dietary Supplements; Diterpenes; Free Radical Scavengers; Ginkgolides; Hemorrhage; Humans; Lactones; Plant Extracts; Platelet Activating Factor | 1998 |